A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Clinical trial NCT07369011 · RECRUITING

Trial details

NCT number: NCT07369011
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sleep Apnea, Obstructive Obesity Overweight

Start date: 2026-02-10
Primary completion: 2028-03-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.